Add
HITK to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| HITK > SEC Filings for HITK > Form 8-K on 30-Nov-2012 | All Recent SEC Filings |
30-Nov-2012
Regulation FD Disclosure, Financial Statements and Exhibits
The following information is being "furnished" in accordance with General
Instruction B.2. of Form 8-K and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liabilities of that section, nor shall it be
deemed to be incorporated by reference in any filing under the Securities Act of
1933, as amended (the "Securities Act"), or the Exchange Act, except as
expressly set forth by specific reference in such filing.
Furnished herewith as Exhibit 99.1 and incorporated by reference herein is a copy of a press release issued by Hi-Tech Pharmacal Co., Inc. (the "Company") on November 30, 2012 relating to a special dividend in the amount of $20,028,897, or $1.50 per share of common stock, payable on December 28, 2012 to stockholders of record on December 13, 2012.
(d) Exhibits.
Exhibit 99.1 Press Release of the Company dated November 30, 2012
Reference is made to the Exhibit Index hereto with respect to the exhibit furnished herewith. The exhibit listed in the Exhibit Index hereto is being "furnished" in accordance with General Instruction B.2. of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.
|
|